Dako Denmark A/S : Dako Launches Advanced Staining Platform at Global
GLOSTRUP, Denmark, March 4, 2013 - Dako, an Agilent Technologies Company and
worldwide provider of cancer diagnostics, unveiled the newest addition to its
IHC portfolio at the 2013 USCAP congress in Baltimore, Md., today. As the
exclusive Platinum Sponsor of the congress, Dako used the opportunity to
present its new advanced staining solution to a global gathering of
pathologists and lab personnel.
The solution, Dako Omnis, comprises hardware, software and reagents. It
automates both IHC and ISH processes, meaning entire patient cases can be
processed simultaneously. This allows pathologists to make quicker, more
informed diagnoses. Oncologists can in turn prescribe relevant therapy with
less anxiety-ridden waiting time for patients.
"This solution provides a breakthrough in addressing some of the hitherto
unmet needs in the anatomic pathology lab," said Dr. Pedro L. Fernandez of the
Hospital Clinic and University of Barcelona, Spain. "Dako adopted a
collaborative approach to bring this solution to market and cooperated with a
global panel of key independent laboratory personnel. For over three years, we
have been involved in the design and development of this solution. Dako has
really listened and responded to the needs of the customer."
"Our customers tell us they are constantly expected to navigate fluctuating
slide numbers with fewer qualified staff and mounting pressure to provide
slides quickly in order to speed diagnosis," said Lisa Miller, corporate vice
president of Global Commercial Business, Dako.
"With continuous loading, batch loading and overnight run options all
available, Dako Omnis sets new standards for what customers can expect from an
automated platform in terms of flexibility, capacity, efficiency and
traceability of slides," she added.
Dako Omnis provides state-of-the-art software to bring lab control to a new
level. Now, key processes such as slide processing and instrument maintenance
can be traced to individual operators, greatly increasing quality control.
As with all Dako's instruments, customers can use the Dako Link software to
connect all solutions and workstations to the laboratory's own information
system. This approach gives the lab manager even more control over the
processing of each individual slide that enters the lab.
Dako Omnis will be offered as part of Dako's current IHC portfolio, which
includes the Autostainer Link 48 instrument, which Dako will continue to
supply and support.
"Each pathology lab is different, and we believe with the addition of Dako
Omnis to our current IHC offering, Dako has an even greater capability to
bring the right solution to the right customer at the right time," said
Miller. "Dako has a reputation for bringing firsts to market, with an
unwavering passion for providing quality solutions. This enables us to offer
our customers efficiency, choice and more time to ultimately provide better
patient care. Advancing pathology is at the heart of what we do, and our
customers tell us our new platform is an important addition."
About Dako - An Agilent Technologies Company
Dako, based in Denmark, is a global leader in tissue-based cancer diagnostics.
Hospital and research laboratories worldwide use Dako's reagents, instruments,
software and expertise to make accurate diagnoses and determine the most
effective treatment for cancer patients. Dako, with 1,200 employees, operates
in more than 100 countries. Dako became part of Agilent Technologies on June
21, 2012. Information about Dako is available at www.dako.com.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is the world's premier measurement company
and a technology leader in chemical analysis, life sciences, diagnostics,
electronics and communications. The company's 20,500 employees serve customers
in more than 100 countries. Agilent had revenues of $6.9 billion in fiscal
2012. Information about Agilent is available at www.agilent.com.
Director, Science Agenda
Dako Denmark A/S
+45 2933 6980
This announcement is distributed by Thomson Reuters on behalf of Thomson
The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other
applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of
information contained therein.
Source: Dako Denmark A/S via Thomson Reuters ONE
Press spacebar to pause and continue. Press esc to stop.